ClinicalTrials.gg

Program

Ningmitai capsule

Also written as “Ningmitai Capsule”.

Its studies are mostly in Prostatitis · Calculi · Ureteral Calculi, led by Xintian Pharmaceutical.

Furthest: phase 4, since May 23, 20235 company-led studies, 1 open or runningNext primary completion: Oct 31, 2028 (phase 4)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Xintian Pharmaceutical51 open or runningphase 4since May 23, 2023May 23, 2023Oct 31, 2028phase 4 · NCT07914686

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. May 23, 2023First study: phase 4 study in Chronic ProstatitisFirst studyNCT05890235 · 323 enrolled · China
  2. Sep 26, 2023Phase 4 study in ProstatitisNCT06064448 · 254 enrolled · China
  3. Oct 23, 2023Phase 4 study in Ureteral CalculiNCT06105827 · 251 enrolled
  4. Nov 19, 2023Phase 4 study in Chronic ProstatitisNCT06159114 · 242 enrolled · China
  5. Oct 27, 2026Phase 4 study in Calculus of Upper Urinary TractNCT07914686 · 100 planned

Ahead

  1. Oct 31, 2028Primary completion: phase 4 study in Calculus of Upper Urinary TractNCT07914686

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07914686Calculus of Upper Urinary Tract4Not yet recruitingOct 31, 2028100
NCT06159114Chronic Prostatitis · China4CompletedJan 31, 2025242
NCT06105827Ureteral Calculi4CompletedApr 25, 2019251
NCT06064448Prostatitis · China4CompletedDec 22, 2022254
NCT05890235Chronic Prostatitis · China4CompletedJul 10, 2022323

How it is read

Names in the registry

  • “Ningmitai capsule”, 3 entries
  • “Ningmitai Capsule”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.